Search

Author/Creator Popovic, Relja

1. Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation. Issue 10 (3rd October 2015)

Authors:
Zhou, Zheng; Gao, Juehua; Popovic, Relja; Wolniak, Kristy; Parimi, Vamsi; Winter, Jane N.; Licht, Jonathan D.; Chen, Yi-Hua
Journal:
Leukemia & lymphoma
Issue:
Volume 56:Issue 10(2015:Oct.)
Page Start:
2895
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy. Issue 2 (3rd March 2021)

Authors:
Handunnetti, Sasanka; Anderson, Mary Ann; Roberts, Andrew W.; Davids, Matthew S.; Ma, Shuo; Boyer, Michelle; Arzt, Jennifer; Masud, Abdullah Al; Popovic, Relja; Jacobson, Amanda; Kim, Su Y.; Seymour, John F.
Journal:
EJHaem
Issue:
Volume 2:Issue 2(2021)
Page Start:
266
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia. Issue 16 (2nd May 2021)

Authors:
Borthakur, Gautam; Odenike, Olatoyosi; Aldoss, Ibrahim; Rizzieri, David A.; Prebet, Thomas; Chen, Chris; Popovic, Relja; Modi, Dimple A.; Joshi, Rujuta H.; Wolff, Johannes E.; Jonas, Brian A.
Journal:
Cancer
Issue:
Volume 127:Issue 16(2021)
Page Start:
2943
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Genetic biomarkers of sensitivity and resistance to venetoclax monotherapy in patients with relapsed acute myeloid leukemia. Issue 8 (16th August 2018)

Authors:
Chyla, Brenda; Daver, Naval; Doyle, Kelly; McKeegan, Evelyn; Huang, Xin; Ruvolo, Vivian; Wang, Zixing; Chen, Ken; Souers, Andrew; Leverson, Joel; Potluri, Jalaja; Boghaert, Erwin; Bhathena, Anahita; Konopleva, Marina; Popovic, Relja
Journal:
American journal of hematology
Issue:
Volume 93:Issue 8(2018:Aug.)
Page Start:
E202
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study. Issue 2 (February 2018)

Authors:
DiNardo, Courtney D; Pratz, Keith W; Letai, Anthony; Jonas, Brian A; Wei, Andrew H; Thirman, Michael; Arellano, Martha; Frattini, Mark G; Kantarjian, Hagop; Popovic, Relja; Chyla, Brenda; Xu, Tu; Dunbar, Martin; Agarwal, Suresh K; Humerickhouse, Rod; Mabry, Mack; Potluri, Jalaja; Konopleva, Marin...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 2(2018)
Page Start:
216
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Identification of recurrent genomic alterations in the apoptotic machinery in chronic lymphocytic leukemia patients treated with venetoclax monotherapy. Issue 2 (24th November 2021)

Authors:
Popovic, Relja; Dunbar, Fengjiao; Lu, Charles; Robinson, Kenneth; Quarless, Danjuma; Warder, Scott E.; Mukherjee, Nabanita; Pesko, John; Souers, Andrew J.; Waring, Jeffrey F.; Davids, Matthew S.; Tausch, Eugen; Stilgenbauer, Stephan; Ross, Jeremy A.; Leverson, Joel D.; Kim, Su Young; Chyla, Brend...
Journal:
American journal of hematology
Issue:
Volume 97:Issue 2(2022)
Page Start:
E47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗